Incruse Ellipta
Drug timelines are a Plus or Pro feature.
10 regulatory and trial events tracked for Incruse Ellipta, covering 2014-04-21 to 2025-07-22. Get the full timeline:
Most recent: EMA Authorised: Incruse Ellipta (previously Incruse) (umeclidinium bromide) — GlaxoSmithKline Trading Services Limited